183 related articles for article (PubMed ID: 15950949)
1. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
[TBL] [Abstract][Full Text] [Related]
2. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
[TBL] [Abstract][Full Text] [Related]
3. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
Awasthi S; Singhal SS; Singhal J; Yang Y; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):721-32. PubMed ID: 12632061
[TBL] [Abstract][Full Text] [Related]
4. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.
Awasthi S; Singhal SS; Singhal J; Cheng J; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):713-20. PubMed ID: 12632060
[TBL] [Abstract][Full Text] [Related]
5. Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.
Singhal SS; Singhal J; Sharma R; Singh SV; Zimniak P; Awasthi YC; Awasthi S
Int J Oncol; 2003 Feb; 22(2):365-75. PubMed ID: 12527936
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer.
Singhal SS; Singhal J; Nair MP; Lacko AG; Awasthi YC; Awasthi S
Int J Oncol; 2007 Mar; 30(3):717-25. PubMed ID: 17273774
[TBL] [Abstract][Full Text] [Related]
7. The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.
Singhal SS; Yadav S; Singhal J; Drake K; Awasthi YC; Awasthi S
FEBS Lett; 2005 Aug; 579(21):4635-41. PubMed ID: 16087181
[TBL] [Abstract][Full Text] [Related]
8. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.
Yadav S; Zajac E; Singhal SS; Singhal J; Drake K; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1003-9. PubMed ID: 15707977
[TBL] [Abstract][Full Text] [Related]
9. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
Sharma R; Singhal SS; Wickramarachchi D; Awasthi YC; Awasthi S
Int J Cancer; 2004 Dec; 112(6):934-42. PubMed ID: 15386349
[TBL] [Abstract][Full Text] [Related]
10. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
Stuckler D; Singhal J; Singhal SS; Yadav S; Awasthi YC; Awasthi S
Cancer Res; 2005 Feb; 65(3):991-8. PubMed ID: 15705900
[TBL] [Abstract][Full Text] [Related]
11. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
Singhal SS; Singhal J; Yadav S; Dwivedi S; Boor PJ; Awasthi YC; Awasthi S
Cancer Res; 2007 May; 67(9):4382-9. PubMed ID: 17483352
[TBL] [Abstract][Full Text] [Related]
12. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance.
Awasthi YC; Sharma R; Yadav S; Dwivedi S; Sharma A; Awasthi S
Curr Drug Metab; 2007 May; 8(4):315-23. PubMed ID: 17504221
[TBL] [Abstract][Full Text] [Related]
13. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
[TBL] [Abstract][Full Text] [Related]
14. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.
Sharma R; Singhal SS; Cheng J; Yang Y; Sharma A; Zimniak P; Awasthi S; Awasthi YC
Arch Biochem Biophys; 2001 Jul; 391(2):171-9. PubMed ID: 11437348
[TBL] [Abstract][Full Text] [Related]
15. RLIP76: A novel glutathione-conjugate and multi-drug transporter.
Singhal SS; Yadav S; Roth C; Singhal J
Biochem Pharmacol; 2009 Mar; 77(5):761-9. PubMed ID: 18983828
[TBL] [Abstract][Full Text] [Related]
16. [Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].
Haixia P; Yifeng B; Honglin H
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):266-71. PubMed ID: 26462890
[TBL] [Abstract][Full Text] [Related]
17. Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76).
Awasthi S; Sharma R; Yang Y; Singhal SS; Pikula S; Bandorowicz-Pikula J; Singh SV; Zimniak P; Awasthi YC
Acta Biochim Pol; 2002; 49(4):855-67. PubMed ID: 12545192
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.
Singhal SS; Yadav S; Singhal J; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2006 Sep; 348(2):722-7. PubMed ID: 16890208
[TBL] [Abstract][Full Text] [Related]
19. Regression of melanoma in a murine model by RLIP76 depletion.
Singhal SS; Awasthi YC; Awasthi S
Cancer Res; 2006 Feb; 66(4):2354-60. PubMed ID: 16489041
[TBL] [Abstract][Full Text] [Related]
20. Targeting p53-null neuroblastomas through RLIP76.
Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]